Best Drug Discovery Software - Page 3

Ångström AI

Ångström AI offers cutting-edge generative AI-based molecular simulations designed to replace traditional wet lab experiments in the pre-clinical drug development process. By integrating quantum-accurate physics models with advanced generative AI, Ångström AI provides pharmaceutical and biotech companies with rapid and precise computational tools to assess the efficacy and safety of new drug candidates. These simulations deliver results that match the accuracy of laboratory experiments but at speeds over 100 times faster, significantly accelerating the drug discovery timeline. Key Features and Functionality: - Quantum-Accurate Simulations: Utilizes the MACE (multi-atomic cluster expansion) physics model to achieve quantum-mechanical accuracy in molecular interactions, ensuring reliable and precise results. - Generative AI Acceleration: Employs diffusion models to expedite complex simulations, making high-fidelity molecular modeling computationally efficient and accessible. - Comprehensive Molecular Analysis: Capable of computing critical properties such as solubility, lipophilicity, and crystal structure stability, providing a holistic understanding of drug behavior. - Physically Constrained AI Models: Ensures that AI-generated simulations adhere strictly to the laws of physics, eliminating the risk of inaccuracies commonly associated with other generative AI technologies. Primary Value and Problem Solved: Ångström AI addresses the inherent challenges of traditional drug development methods, which are often time-consuming and costly. By substituting wet lab experiments with AI-driven simulations, the platform enables researchers to rapidly and accurately predict molecular interactions, thereby streamlining the pre-clinical phase of drug development. This innovation not only reduces the time and resources required but also enhances the precision of early-stage drug assessments, ultimately accelerating the delivery of safe and effective therapeutics to the market.

Anivance AI Corporation

Anivance AI is a biotech startup that provides AI with organ-on-a-chip technology to transform drug discovery and preclinical research.

Aspect Analytics

Aspect Analytics offers consultancy services, home-grown software, development of workflows, and customization of software.

Atlas Discovery

Atomic AI

Atomic AI is a biotechnology company at the forefront of integrating artificial intelligence with structural biology to revolutionize RNA drug discovery. By combining advanced machine learning models with proprietary wet-lab assays, Atomic AI's Platform for AI-driven RNA Structure Exploration (PARSE) enables the development of highly potent and selective RNA-targeted small molecules and RNA-based medicines. This innovative approach addresses diseases traditionally considered undruggable at the protein level, particularly in oncology and neurodegenerative disorders. Key Features and Functionality: - PARSE Platform: A proprietary R&D platform that merges deep learning foundation models with in-house wet-lab assays to discover and develop RNA-targeted therapeutics. - ATOM-1™ Model: A pioneering large language model utilizing chemical mapping data to predict RNA structural and functional properties, enhancing the design of RNA-based modalities such as small molecules, mRNA vaccines, siRNAs, and circular RNA. - Interdisciplinary Expertise: A team of specialists in machine learning, RNA biology, and drug discovery, committed to bold innovation and collaborative problem-solving. Primary Value and Problem Solved: Atomic AI's platform overcomes a significant barrier in drug discovery by enabling the targeting of RNA structures, which were previously considered undruggable at the protein level. This capability opens new avenues for treating complex diseases, particularly in oncology and neurodegenerative conditions, by developing highly selective RNA-targeted small molecule splicing modulators. By harnessing the synergy between AI and structural biology, Atomic AI accelerates the development of innovative therapeutics, offering hope for patients with limited treatment options.

Aurora Drug Discovery Software

Aurora employs quantum mechanics, thermodynamics, and an advanced continuous water model for solvation effects to calculate ligand's binding affinities. This approach differs dramatically from scoring functions that are commonly used for binding affinity predictions. By including the entropy and aqueous electrostatic contributions in to the calculations directly, Aurora algorithms produce much more accurate and robust values of binding free energies.

AutoChrom

Method development software for the chromatography expert. AutoChrom helps experts develop chromatographic separations using QbD principles. It uses a workflow-based structure to streamline and track a project.

Basesoft PharmaSuite

The software that will help improve the safety, traceability, quality, agility and integration of your Pharmacotechnical and Drug Preparation Unit.

Bexorg

Bexorg is a pioneering biotechnology company dedicated to transforming central nervous system (CNS) drug discovery and development. Utilizing its proprietary BrainEx platform, Bexorg restores metabolic and molecular activity in postmortem human brains, enabling the generation of high-fidelity, clinically predictive data. This innovative approach allows for the study of brain connectivity, circuit function, and disease processes in a way previously unattainable, providing unprecedented insights into human neurobiology. Key Features and Functionality: - BrainEx Platform: A cutting-edge whole-brain perfusion technology that maintains isolated human and pig brains in a metabolically active state, facilitating real-time tracking of transcriptomic, proteomic, metabolic, and biomarker responses. - XO Digital Engine: An AI-driven system that learns from each experiment, creating a closed-loop of in-silico prediction and wet-lab validation, thereby enhancing the efficiency and accuracy of CNS drug discovery. - Comprehensive Human Brain Datasets: By generating extensive human brain molecular data, Bexorg trains predictive models across various neurological diseases, leading to the identification of novel targets and biomarkers. Primary Value and User Solutions: Bexorg addresses the high failure rates in CNS drug development by providing a platform that closely mirrors human brain physiology. This approach de-risks the drug development process by enabling preclinical testing of therapeutics in metabolically active whole human brains, offering significant advantages over traditional models. By delivering detailed insights into drug distribution, mechanism of action, target engagement, and CNS biomarker identification, Bexorg empowers pharmaceutical partners to make informed decisions, ultimately accelerating the development of effective therapies for neurological disorders.

Bindwell

Bindwell is a Biotech company that uses AI to develops safer pesticides.

BioGeometry

BioGeometry is a pioneering digital biology company specializing in the application of generative AI to protein design. Their AI-driven platform, GeoBiologics, integrates advanced geometric deep learning models with high-throughput wet-lab validation, creating a closed-loop system that enhances the precision and efficiency of protein design and optimization. This innovative approach addresses traditional challenges in biomedicine and synthetic biology, such as high costs, lengthy development cycles, and low success rates, by streamlining the protein discovery process. Key Features and Functionality: - GeoBiologics Platform: Combines generative AI with wet-lab validation to facilitate rapid and accurate protein design. - GeoFlow Model: A generative AI model that unifies sequence, structure, and function of biomolecules, enabling precise and swift programming of next-generation proteins. - High-Throughput Validation: Ensures that AI-generated protein designs are experimentally validated, enhancing reliability and effectiveness. Primary Value and Solutions: BioGeometry's platform revolutionizes protein design by significantly reducing the time and cost associated with developing new biologics and synthetic biology applications. By leveraging generative AI, BioGeometry enables the creation of tailored protein solutions that address complex challenges in health and environmental sectors, ultimately contributing to a greener, healthier, and more sustainable planet.

BioMap

Biotronics AI

Biotronics AI is a pioneering company dedicated to transforming the life sciences sector through advanced technologies such as machine learning and quantum computing. Their mission is to develop innovative solutions that address complex challenges in healthcare, forensic science, and sustainability. Key Features and Functionality: - MediSight: A platform designed to receive, analyze, and diagnose various types of biomedical data. Its standout feature is the ability to simulate the progression of lesion findings in subsequent phases of a disease, providing valuable insights into disease development. - ForenSight: An open-source suite of tools developed to assist forensic genetic experts in performing DNA comparisons. It significantly reduces the time required for DNA comparisons from days to mere seconds, enhancing the efficiency of forensic investigations. - Bio-Q: A quantum machine learning algorithm designed to calculate the molecular structure of cellular and nuclear receptors using genomic information. Bio-Q facilitates the design of corresponding molecular microanatomy, making it the first quantum circuit developed for this purpose. Primary Value and User Solutions: Biotronics AI addresses critical issues in the life sciences by providing technologies that enhance diagnostic accuracy, expedite forensic analyses, and accelerate drug discovery processes. By integrating machine learning and quantum computing, their solutions offer unprecedented speed and precision, ultimately improving patient outcomes, supporting justice systems, and promoting sustainability initiatives.

BIOVIA Discovery Studio

Discovery Studio is BIOVIA's comprehensive predictive science application for the Life Sciences. BIOVIA Discovery Studio 2019 stands as BIOVIA's major release for predictive sciences and modeling and simulation in the life sciences

Boltzmann Labs

Boltzmann Labs is a deep-tech Artificial Intelligence (AI) company specialising in AI-powered drug discovery, computational biology and scientific research automation. We develop advanced AI solutions for protein engineering, small molecule drug design, RNA design, enzyme engineering, synthetic chemistry and molecular simulations. Our AI-powered discovery platform enables pharmaceutical companies, biotechnology startups, academic institutions and research organisations to accelerate R&D workflows, optimise molecular design and advance scientific innovation. Our flagship innovation, Agent Scientist, is an open-source AI agent system for scientific research that integrates AI agents, scientific tools, research skills and knowledge sources to automate complex scientific workflows and accelerate AI-driven scientific discovery.